Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis.
van den Elskamp IJ, Lembcke J, Dattola V, Beckmann K, Pohl C, Hong W, Sandbrink R, Wagner K, Knol DL, Uitdehaag B, Barkhof F.
van den Elskamp IJ, et al. Among authors: lembcke j.
Mult Scler. 2008 Jul;14(6):764-9. doi: 10.1177/1352458507087842.
Mult Scler. 2008.
PMID: 18611989
Clinical Trial.